Speakers & Planning Committee


Tamara Fountain MD Photo

Tamara Fountain MD

Professor of Ophthalmology
Rush University Medical Center

Tamara Fountain, MD is professor of ophthalmology at Rush University Medical Center and section chair emeritus of oculofacial plastic surgery. She maintains a private practice near her home on Chicago’s North Shore, a day’s drive from where she grew up in Minneapolis, Minnesota.

Dr. Fountain graduated with a B.A. from Stanford University and obtained her M.D. from Harvard Medical School. After completing residency in ophthalmology at Johns Hopkins' Wilmer Eye Institute, she returned to California for fellowship training in oculoplastic surgery at Doheny Eye Institute/University of Southern California.

Dr. Fountain was appointed to the board of directors of the American Board of Ophthalmology in 2022 and was President of the American Academy of Ophthalmology in 2021. She is Past-President of the American Society of Ophthalmic Plastic and Reconstructive Surgery (ASOPRS), where she has received the Robert Kennedy Presidential and Orkan Stasior Leadership Awards for service to the Society.

Dr. Fountain served 15 years with the Ophthalmic Mutual Insurance Company chairing the Audit, Strategic Planning, Risk Management and Insurance/Marketing committees before being elected Chair of the Board of Directors. She is past-president of the Illinois Society of Eye Physicians and Surgeons and has been involved in programming for the American Ophthalmological Society, Women in Ophthalmology and the Chicago Ophthalmological Society. She is a past Alumni Fund Chair for Harvard Medical School.

Outside medicine, Dr. Fountain is a news and podcast junkie and enjoys traveling with family and speaking at conferences (Pre-Covid) around the world. She plays tennis year-round and when Chicago weather permits, takes long bike rides gets in a few rounds of golf. Dr. Fountain feels fortunate to have led a life of service to patients as well as to the profession of ophthalmology.

Dr. Fountain has indicated no disclosures with an ineligible entity.

Mitchell Jackson MD Photo

Mitchell Jackson MD

Founder and Owner
Lake Villa IL

Mitchell Jackson, MD is the Founder and Owner of Jacksoneye, his private practice of 30 years located in Lake Villa, Illinois. He graduated from Pomona College, completed his medical training at FUHS/The Chicago Medical School, and completed his Ophthalmology residency at the University of Chicago Hospitals. He serves on the editorial advisory boards of Cataract and Refractive Surgery Today, Ophthalmology Management, Presbyopia Physician, Advanced Ocular Care, Corneal Physician, Ocular Surgery News, and Ophthalmology 360. Dr. Jackson is also a board member and VP of the American College of Eye Surgeons (ACES), founding member of the American College of Ophthalmic Surgeons (AECOS), and founding member and past 2018 President of the Cataract External Disease and Refractive Surgery Society (CEDARS/ASPENS). In addition to being selected to the top 250 PS250 Premier Surgeon list, OSN300 top 300 Refractive Surgeon list, and ASCRS clinical subcommittee for cataract and refractive surgery, Dr. Jackson has been involved in many FDA pharmaceutical and surgical clinical studies (Dry Eye, Viscoelastics, IOLs, Presbyopia, topical NSAIDs and steroids) over the tenure of his practice, including serving as the Global Medical Director of ACE Vision Group. He also has his own monthly column entitled “The Premium Channel” in Ocular Surgery News/Healio which launched in April 2013. He recently was the recipient of the 2018 Annual Millenial Award, the AAO Board of Trustees Achievement Award in August of 2018, the 2018 Innovation and Founders Award for Cedars Aspens, the 2020 Albert Nelson Marquis Lifetime Achievement Award for Ophthalmology, selected by his peers as Best Cataract Surgeon in America 2021, and selected by Media Mice as a top 50 global KOL (key opinion leader) influencer 2021.

Dr. Jackson has described the following relationships: Relationships: Consultants: Lensar, Shareholder/Consultant: Ace Vision Group Consultant/Faculty: Alcon, Bausch & Lomb, Johnson & Johnson

Daniel Martin MD Photo

Daniel Martin MD

Cleveland Clinic Cole Eye Institute
Barbara and A. Malachi Mixon III Institute Chair in Ophthalmology
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
Professor of Ophthalmology
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
Cleveland OH

Daniel F. Martin MD is Chair of the Cleveland Clinic Cole Eye Institute, the Barbara and A. Malachi Mixon III Institute Chair in Ophthalmology, and Professor of Ophthalmology in the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. Dr. Martin completed medical school at The Johns Hopkins University School of Medicine followed by residency and chief residency in ophthalmology at Emory University School of Medicine. He completed a fellowship in Vitreoretinal Surgery and Diseases at Duke University Eye Center followed by a two-year fellowship in Uveitis and Ocular Immunology at the National Eye Institute of the National Institutes of Health.

Dr. Martin currently serves as the Network Chair for the DRCR Retina Network. Dr. Martin previously served as the Study Chair for the Comparison of AMD Treatments Trials (CATT) and has served as Study Chair for many other national clinical trials including those that led to FDA approval of the ganciclovir implant and valganciclovir. He has served as PI, member of the DSMC, and/or member of the Steering Committee for dozens of other studies including AREDS, SOCA, and MUST. He has published more than 220 peer-reviewed articles, delivered 40 named lectures, and delivered more than 400 invited lectures. Dr. Martin has been the recipient of numerous awards including the 74th Edward Jackson Memorial Lecture, the AAO Lifetime Achievement Award, the AAO Secretariat Award, the AAO Senior Achievement Award, the Heed-Gutman Award from the Society of Heed Fellows, the J. Donald M. Gass Medal from the Macula Society, the Roger Johnson Award in AMD Research from the University of Washington, the Pyron Award and the Crystal Apple Award from the American Society of Retina Specialists (ASRS), the Rosenthal Young Investigator Award from the Macula Society, the Sam and Maria Miller Award for Scientific Achievement in Clinical Research from the Cleveland Clinic, the J. Donald M. Gass Lectureship Award from the Retina Society, and the Cless Medal. Dr Martin has previously served on the Board of Governors for the Cleveland Clinic.

Dr. Martin has indicated no disclosures with an ineligible entity.

Richard Schroeder MD Photo

Richard Schroeder MD

Indiana University Health

Richard Schroeder MD is a glaucoma specialist at the Indiana University Health. He completed his undergraduate degree at the University of Notre Dame. He then earned his medical degree at the University of Chicago Pritzker School of Medicine followed by an ophthalmology residency and glaucoma fellowship at Washington University in St. Louis. Dr. Schroeder has a particular interest in surgical management of glaucoma as well as resident and fellow education.

Dr. Schroeder has indicated no disclosures with an ineligible entity.

OMIC Presentation

Thursday Evening, March 9

OMIC malpractice prevention presentation

In addition to the above scientific presentations, the Thursday night dinner program features a valuable presentation on malpractice prevention offered by Dr. Dan Briceland of Ophthalmic Mutual Insurance Corporation and Dr. Aaron Weingeist. Be sure to sign in while in the presentation room to ensure your OMIC discount. Current WAEPS members earn a 10% discount for completion of this activity www.omic.com

Daniel Briceland MD Photo

Daniel Briceland MD

American Academy of Ophthalmology

Daniel J. Briceland, MD is the President of the American Academy of Ophthalmology. He was elected American Academy of Ophthalmology’s Senior Secretary for Advocacy in 2015. He is a graduate of the Academy’s Leadership Development Program, LDPII, class of 2000. Dr. Briceland also serves on the Academy’s Executive Committee. Dr. Briceland previously served as the Academy’s Secretary for State Affairs, and as an Associate for Secretary for State Affairs. Additionally, he previously was a member of the Academy’s Nominating Committee, Awards Committee and Committee on Aging. He served for six years as director of the Academy’s Leadership Development Program, overseeing the development of future leaders of state, subspecialty, and specialized interest societies and continues to be involved in this effort.

Dr. Briceland has been an Ophthalmic Mutual Insurance Company Director since 2012, and just finished his three-year term as Chair of the Board of Directors. He has held leadership roles on the Executive, Audit, Reinsurance, and Claims Committees.

Dr. Briceland has indicated no disclosures with an ineligible entity.

Jane Mock CPHRM

San Francisco CA
Aaron Weingeist MD Photo

Aaron Weingeist MD

Dr. Weingeist has indicated no disclosures with an ineligible entity.

Planning Commitee

Susanna Barnett


Susanna Barnett has indicated no disclosures with an ineligible entity.

Paul Griggs MD


Dr. Griggs has indicated no disclosures with an ineligible entity.

Russell Van Gelder MD

Dr. Van Gelder has indicated no disclosures with an ineligible entity.